Envestnet Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-16,500
| Closed | -$16.8K | – | 4217 |
|
2024
Q2 | $16.8K | Hold |
16,500
| – | – | ﹤0.01% | 4144 |
|
2024
Q1 | $30.2K | Buy |
16,500
+2,500
| +18% | +$4.58K | ﹤0.01% | 4129 |
|
2023
Q4 | $17.4K | Sell |
14,000
-274
| -2% | -$340 | ﹤0.01% | 4023 |
|
2023
Q3 | $16.3K | Buy |
14,274
+274
| +2% | +$312 | ﹤0.01% | 3982 |
|
2023
Q2 | $12.8K | Buy |
+14,000
| New | +$12.8K | ﹤0.01% | 3934 |
|
2018
Q3 | – | Sell |
-2,025
| Closed | -$20K | – | 1274 |
|
2018
Q2 | $20K | Sell |
2,025
-217
| -10% | -$2.14K | ﹤0.01% | 2419 |
|
2018
Q1 | $21K | Sell |
2,242
-109
| -5% | -$1.02K | ﹤0.01% | 2354 |
|
2017
Q4 | $35K | Buy |
2,351
+243
| +12% | +$3.62K | ﹤0.01% | 2411 |
|
2017
Q3 | $41K | Buy |
2,108
+134
| +7% | +$2.61K | ﹤0.01% | 2329 |
|
2017
Q2 | $28K | Sell |
1,974
-15
| -0.8% | -$213 | ﹤0.01% | 2522 |
|
2017
Q1 | $18K | Buy |
1,989
+868
| +77% | +$7.86K | ﹤0.01% | 2684 |
|
2016
Q4 | $12K | Sell |
1,121
-647
| -37% | -$6.93K | ﹤0.01% | 2742 |
|
2016
Q3 | $16K | Sell |
1,768
-179
| -9% | -$1.62K | ﹤0.01% | 2835 |
|
2016
Q2 | $15K | Sell |
1,947
-420
| -18% | -$3.24K | ﹤0.01% | 2997 |
|
2016
Q1 | $21K | Sell |
2,367
-510
| -18% | -$4.53K | ﹤0.01% | 2953 |
|
2015
Q4 | $37K | Buy |
+2,877
| New | +$37K | ﹤0.01% | 2747 |
|